XClose

EGA Institute for Women's Health

Home
Menu

Prenatal Cell and Gene Therapy

Professor Anna David leads a team developing prenatal treatment of severe early onset and life-threatening disorders using gene and cellular therapy, and to investigate the efficacy, safety and ethical issues of such treatment.

Professor Anna David

Professor Anna David

Research Group Lead

IRIS profile

Background

Research into fetal gene therapy began under a 5 year MRC Programme grant (Professor Charles Rodeck) in collaboration with the Gene Therapy Research Group (Professor Charles Coutelle) at Imperial College, London in 2000. Dr David obtained a PhD on clinically applicable methods of delivering fetal gene therapy in 2005 at UCL and she established the group in 2007.

Current research projects

Maternal gene therapy
Fetal gene therapy
Fetal stem cell gene therapy
In utero stem cell transplantation
Healing the amniotic membrane
Biobanking fetal stem cells for therapy
Imaging for fetal therapy
Developing obstetric therapies
Ethics of prenatal therapies
Public engagement
Prenatal therapy charity
News

Twitter

@PrenatalTherapy: Obstetrician and specialist in maternal fetal medicine, with an interest in developing prenatal therapies for pregnancy complications and congenital disease

@FP7EVERREST: Does vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction?

Further information